Skip to main content
OpenTrials

Clinical trial condition

Endocrine System Diseases

Explore clinical trials studying Endocrine System Diseases. Study availability and eligibility vary by location and protocol.

26,519 public trials 3,597 recruiting studies
Refine in advanced search Browse all conditions

Endocrine System Diseases trial results

Terminated

AVAST Anomalies Vasculaires Associées au Syndrome de Turner (Vascular Abnormalities Associated With Turner Syndrome)

NCT02250456

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Chromosome Disorders, +25 more
Locations
  • Service de Chirurgie et Médecine Vasculaire, CHU Jean Minjoz Besançon, France
  • Service d'Angiologie, CHU Bocage Dijon, France
  • Service de gynécologie, Centre Médico Chirurgical Obstétrical, Hôpitaux Universitaires Schiltigheim, France
  • Service d'endocrinologie, Hôpital Civil, Hôpitaux Universitaires Strasbourg, France
View Trial Details
Terminated

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View all 17 locations
View Trial Details
Terminated

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

NCT05226507

Conditions
ARID1A Gene Mutation, Adenocarcinoma, Adnexal Diseases, +24 more
Locations
  • Honor Health Phoenix, Arizona, United States
  • UC San Diego Health - Moores Cancer Center La Jolla, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale Gynecologic Oncology New Haven, Connecticut, United States
View all 22 locations
View Trial Details
Terminated

Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod

NCT00799110

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions